CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-07-30 | Sawhney Amarpreet President and CEO | Conversion | +16,075 | 394,862 | ||
| 2014-07-30 | Sawhney Amarpreet President and CEO | Purchase | +76,922 | $13.00 | $1000K | 471,784 |
| 2014-07-30 | Sawhney Amarpreet President and CEO | Conversion · Series A Preferred Stock | −320,836 | 0 | ||
| 2014-07-30 | Sawhney Amarpreet President and CEO | Conversion · Series C Preferred Stock | −61,664 | 0 | ||
| 2014-07-30 | Sawhney Amarpreet President and CEO | Conversion · Series C Preferred Stock | −243,902 | 0 | ||
| 2014-07-30 | Sawhney Amarpreet President and CEO | Conversion · Series C Preferred Stock | −42,440 | 0 | ||
| 2014-07-30 | Chadha Jaswinder Director | Conversion | +92,570 | 130,448 | ||
| 2014-07-30 | Chadha Jaswinder Director | Conversion · Series A Preferred Stock | −100,000 | 0 | ||
| 2014-07-30 | Chadha Jaswinder Director | Conversion · Series B Preferred Stock | −27,144 | 0 | ||
| 2014-07-30 | Chadha Jaswinder Director | Conversion · Series C Preferred Stock | −117,243 | 0 | ||
| 2014-07-30 | LINDSTROM RICHARD L MD Director | Conversion | +18,939 | 18,939 | ||
| 2014-07-30 | LINDSTROM RICHARD L MD Director | Conversion · Series A Preferred Stock | −50,000 | 0 | ||
| 2014-07-30 | Warden Charles M Director | Conversion | +2,944,993 | 2,944,993 | ||
| 2014-07-30 | Warden Charles M Director | Conversion | +17,391 | 17,391 | ||
| 2014-07-30 | Warden Charles M Director | Conversion · Series A Preferred Stock | −198,826 | 0 | ||
| 2014-07-30 | Warden Charles M Director | Conversion · Series A Preferred Stock | −1,174 | 0 | ||
| 2014-07-30 | Warden Charles M Director | Conversion · Series B Preferred Stock | −1,619,102 | 0 | ||
| 2014-07-30 | Warden Charles M Director | Conversion · Series B Preferred Stock | −9,563 | 0 | ||
| 2014-07-30 | Warden Charles M Director | Conversion · Series C Preferred Stock | −2,433,816 | 0 | ||
| 2014-07-30 | Warden Charles M Director | Conversion · Series C Preferred Stock | −14,372 | 0 |
Page 25 of 27 · 522 trades